Trexquant Investment’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Trexquant Investment’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-24,360	Closed	-$414K	–	1626
2020 Q4	$414K	Buy	+24,360	New	+$305K	0.04%	522
2019 Q1	–	Sell	-35,716	Closed	-$332K	–	1433
2018 Q4	$332K	Buy	35,716 +4,872	+16%	+$58K	0.02%	751
2018 Q3	$429K	Buy	+30,844	New	+$459K	0.03%	595
2017 Q2	–	Sell	-21,700	Closed	-$784K	–	1307
2017 Q1	$784K	Buy	+21,700	New	+$957K	0.1%	361
2016 Q1	–	Sell	-21,232	Closed	-$881K	–	1267
2015 Q4	$881K	Sell	21,232 -4,606	-18%	-$154K	0.08%	438
2015 Q3	$397K	Sell	25,838 -11,467	-31%	-$246K	0.03%	804
2015 Q2	$926K	Buy	+37,305	New	+$831K	0.1%	361

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Trexquant Investment's FPRX Position: Q1 2021 in Review

Trexquant Investment sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 24,360 shares — an estimated $414K sold.

Trexquant Investment first reported a position in FPRX in Q2 2015 and held it in 7 quarters. The position peaked at $926K in Q2 2015. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

Trexquant Investment reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Trexquant Investment sold 24,360 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $414K.
Trexquant Investment first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 7 quarters.
Trexquant Investment's Five Prime Therapeutics, Inc. position peaked at $926K in Q2 2015.
147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Trexquant Investment's 13F filing for Q1 2021, filed 13 May 2021.